Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1986-6-6
pubmed:abstractText
After giving their informed consent, 16 healthy male physical education students received daily dose of 3 X 60 mg diltiazem or placebo respectively in a double-blind cross-over experimental set-up for consecutive test phases of 3 weeks each. The behaviour of physical performance capacity, metabolism and hormones under diltiazem was investigated during incremental performance tests and during continuous endurance tests on the treadmill. Maximum performance capacity and maximum oxygen uptake as well as endurance capacity remained uninfluenced. Under maximum as well as under lower work loads heart rates were reduced by 3-10 beats/min. Carbohydrate and lipid metabolism including the lipoproteins as well as HGH, cortisol and insulin showed the same behaviour under diltiazem and placebo. Adrenaline and noradrenaline in blood plasma also remained uninfluenced. An impairment of physical performance capacity under diltiazem is not to be expected. This finding is of major importance for persons treated with diltiazem who engage in sport.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0300-5860
pubmed:author
pubmed:issnType
Print
pubmed:volume
75
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
99-106
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
[Physical performance capacity, metabolism and hormonal behavior as affected by diltiazem].
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Randomized Controlled Trial, Controlled Clinical Trial